Emerging Company TRANSACTIONAL

Getting a startup off the ground? Learn how we can help at WilmerHaleLaunch.com.


WilmerHale's Emerging Company Practice has helped thousands of entrepreneurs successfully launch their businesses; raise billions in angel, venture and strategic financing; and take their companies to sale, IPO and market leadership.

Our more than 100 dedicated corporate lawyers are stationed in some of the most active startup markets, including Silicon Valley, Boston, New York and Europe. We have a longstanding tradition of representing emerging companies and entrepreneurs across a wide range of industries, and offer strategic advice and an indispensable business perspective that is critical to our clients' success. Our team-oriented approach to service gives clients the flexibility to call on a number of experienced lawyers at any time, and our innovative QuickLaunch Program enables us to provide the highest level of responsiveness in a cost-effective manner. Additionally, we are able to draw on the full spectrum of renowned services offered by the firm—from intellectual property and labor and employment to tax, litigation, regulatory issues and beyond. We are extraordinarily proud of the innovative clients we serve, many of whom have helped change the way we all work, think and live.

Contacts

Sort By
Buckland, Peter

Peter Buckland

Vice Chair, Corporate Practice Group

Co-Chair, Emerging Company Practice

+1 650 858 6036 (t)

peter.buckland@wilmerhale.com

Gammell, David

David D. Gammell

Co-Chair, Emerging Company Practice

+1 617 526 6839 (t)

david.gammell@wilmerhale.com

Bain, Mick

Mick Bain

Partner

+1 617 526 6158 (t)

michael.bain@wilmerhale.com

Boot, Jeannette K.

Jeannette K. Boot

Partner

+1 212 295 6507 (t)

jeannette.boot@wilmerhale.com

Borden, Mark G.

Mark G. Borden

Partner

+1 617 526 6675 (t)

mark.borden@wilmerhale.com

Bothwick, Jay E.

Jay E. Bothwick

Partner

+1 617 526 6526 (t)

jay.bothwick@wilmerhale.com

Braun, Martin

Dr. Martin Braun

Partner

+49 69 27 10 78 207 (t)

martin.braun@wilmerhale.com

Brown, Lillian

Lillian Brown

Partner

+1 202 663 6743 (t)

lillian.brown@wilmerhale.com

Buckland, Peter

Peter Buckland

Partner

+1 650 858 6036 (t)

peter.buckland@wilmerhale.com

Coates, Sam

Samuel S. Coates

Partner

+1 650 858 6000 (t)

samuel.coates@wilmerhale.com

Experience

We work with founders to properly set up their companies; review business plans and identify companies' key strengths and weaknesses before approaching financing sources; license core technology; develop strategies to obtain funding and negotiate terms for initial and later-stage financings; prepare and implement key agreements with management, employees, consultants and advisors; design equity incentive plans; and advise clients on how best to achieve liquidity. We also attend board meetings and offer strategic advice and counseling on important business decisions, as well as guidance on forming and running an effective board of directors.

Our lawyers represent life sciences companies—including those in the biotechnology, medical device and healthcare sectors—as well as technology companies in a broad range of industries, including consumer Internet, fintech, energy, material science, cybersecurity, digital media, mobile technology, robotics, software, hardware, big data, and clean technology. In addition to our corporate experience, we are able to tap into the deep technical and scientific knowledge of our attorneys who hold degrees in fields such as biochemistry, biology, biomedical engineering, chemical engineering, chemistry, computer science, electrical engineering, genetics, immunology, information systems, mathematics, mechanical engineering, medicine, microbiology, organic chemistry and systems engineering. As a result, we have a sophisticated understanding of the important technical and intellectual property issues facing companies in these sectors.

Venture capital deals are a cornerstone of our practice, and reflect our longstanding focus on emerging technology and life sciences companies. In 2015, we served as counsel in more than 250 venture financings raising nearly $5 billion, including some of the largest and most prominent deals of the year. Since 2004, we have handled more than 3,000 venture financings with total proceeds in excess of $30 billion. Learn more about our venture capital capabilities.

Publications & News

View

May 23, 2016

WilmerHale Counsels Kite Hill in $18 Million Funding Round From Lead Investors General Mills and CAVU Venture Partners

WilmerHale represented Kite Hill—a brand that makes plant-based cheeses, yogurts, cream cheese-style spreads and other dairy analogue products sold to consumers in Whole Foods Markets and directly to restaurants and wholesalers—in raising $18 million, with lead investments from General Mills' new venture unit and CAVU Venture Partners.

May 20, 2016

Securities Crowdfunding Rules Go Live

An article by Glenn Luinenburg and Jessica Wade, published by the Daily Journal, identifies the four key questions for entrepreneurs to consider as they explore whether to use the Securities and Exchange Commission's recently adopted rules to permit crowdfunding under the JOBS Act of 2012.

May 16, 2016

Congress Creates Federal Right of Action for Trade Secret Misappropriation

On May 11, President Obama signed into law the Defend Trade Secrets Act of 2016, which enables companies to go to federal court to sue for misappropriation of trade secrets.

May 16, 2016

WilmerHale Counsels Accion Systems in Raising $7.5 Million in Series A Funding

WilmerHale represented Accion Systems Inc., a space technology startup led by MIT graduates, in raising $7.5 million in Series A funding.

May 3, 2016

Selected 2016 Life Sciences Transactions

Recognized both globally and nationally for its leading life sciences practice, WilmerHale has more than four decades of experience representing biotechnology, pharmaceutical and medical device companies at all stages of growth, as well as venture capitalists and investment banks.

May 3, 2016

Selected 2016 Technology Transactions

For more than four decades, we have represented technology clients in venture capital financings, public offerings, and mergers and acquisitions; handled their licensing, outsourcing, services, joint venture, development and distribution transactions throughout the world; protected their innovations through patent prosecution and portfolio development; defended their interests in enterprise-critical patent litigation; and navigated regulatory issues vital to their success.

May 2, 2016

WilmerHale Expands West Coast Corporate Practice With Two Partner Hires

WilmerHale is pleased to welcome Partners Christopher Rose and Eric Hwang to the firm's Los Angeles and Palo Alto offices, respectively.

April 15, 2016

Kala Pharmaceuticals Announces Closing of $68 Million Series C Financing

On April 13, 2016, Kala Pharmaceuticals, Inc., a clinical-stage pharmaceutical company focused on developing innovative ophthalmic products based on its proprietary mucus-penetrating particle technology, announced that it closed a $68 million Series C preferred stock financing.

March 27, 2016

WilmerHale Lawyers and Practices Recognized in 2016 Edition of Chambers USA

Chambers USA: America's Leading Lawyers for Business announced its final rankings for the 2016 edition, with WilmerHale ranking among the nation's best in 47 practice area categories. Chambers also ranked 82 WilmerHale lawyers as leaders in their respective fields.

March 24, 2016

2016 Corporate Reports

WilmerHale's annual IPO, Venture Capital and M&A Reports offer insights into market conditions and provide comprehensive statistics and analysis that are hard to find elsewhere.

2015 Reports

WilmerHale's annual IPO, Venture Capital and M&A Reports offer insights into market conditions and provide comprehensive statistics and analysis that are hard to find elsewhere.

Our  2015 IPO Report offers a detailed analysis of, and outlook for, the IPO market. The report features regional breakdowns, useful IPO market metrics, an update on the rates of adoption of various elements of JOBS Act relief available to emerging growth companies, and helpful tips on how to keep your directed share program company-friendly. We examine the pros and cons of employee stock purchase plans; review various SEC, stock exchange and other considerations around director independence; address key areas of regulatory diligence for companies going public; and offer a helpful walk-through of the process of SEC review of Form S-1 registration statements in the lead-up to an IPO.

The  2015 Venture Capital Report offers an in-depth analysis of, and outlook for, the US and European venture capital markets. The report features industry and regional breakdowns; an analysis of trends in venture capital financing, convertible debt and VC-backed company M&A deal terms; and a look at important considerations for startup founders weighing the costs, benefits and optimal timing for company incorporation.

Our  2015 M&A Report contains a detailed review of, and outlook for, the global M&A market. Other highlights include a comparison of deal terms in public and private acquisitions, updates on takeover defenses and the current climate around proxy access, and a look at the use of social media by public companies and activist shareholders in contested situations. We also examine recent trends in merger control, discuss lessons from Cigna v. Audax for sales of VC-backed companies structured as mergers, address the challenges posed by pre-IPO acquisitions, and survey key terms in sales of VC-backed companies.

Each report also includes a center spread showcasing prominent recent transactions in each area and company counsel rankings from independent sources showing WilmerHale's preeminence as counsel in IPOs, VC financings and sales of VC-backed companies.

To request a hard copy of any of the reports, contact the WilmerHale Client Development Department at ClientDevelopment@wilmerhale.com or call +1 617 526 5600.

 

QuickLaunch Program

WilmerHale's QuickLaunch Program, powered by more than 100 lawyers across all of our offices, is a platform for qualified startups and entrepreneurs to receive the critical guidance and legal advice they need to get off the ground and gain a competitive advantage. QuickLaunch members have access to a community of like-minded entrepreneurs who face many of the same challenges related to their new ventures. Additional benefits include: 

  • introductions to venture capitalists, angels and other investors;
  • access to potential recruits, mentors, advisors and preferred providers;
  • an audience of peers and influencers to help refine and promote your startup;
  • invitations to our private QuickLaunch events in Boston, New York and Silicon Valley;
  • legal guidance on everything from company formation, expansion and patent protection to securing financing and exit strategies; and     
  • the ability to manage costs through free services and deferred, fixed and/or discounted rates.

Through the QuickLaunch Program (formerly known as QuickStart), our lawyers leverage their institutional knowledge and deep experience to deliver services on a responsive and efficient basis. We have helped thousands of entrepreneurs launch and grow their businesses, and in this time we have gained a deeper understanding of the types of legal and business support that lead to startup success.

Contact us to learn more.